Atika Capital Management LLC Regeneron Pharmaceuticals, Inc. Transaction History

Atika Capital Management LLC

$874 Million
Q3 2024

A detailed history of Atika Capital Management LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Atika Capital Management LLC holds 8,500 shares of REGN stock, worth $5.97 Million. This represents 1.02% of its overall portfolio holdings.

Number of Shares

8,500

Previous 9,500 10.53%

Holding current value

$5.97 Million

Previous $9.98 Million 10.51%

% of portfolio

1.02%

Previous 1.19%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$1024.09 - $1201.76 $1.02 Million - $1.2 Million	-1,000 Reduced 10.53%	8,500 $8.94 Million
Q2 2024 Aug 13, 2024	BUY	$883.2 - $1071.19 $618,240 - $749,833	700 Added 7.95%	9,500 $9.98 Million
Q1 2024 May 14, 2024	BUY	$902.69 - $993.35 $7.94 Million - $8.74 Million	8,800 New	8,800 $8.47 Million
Q1 2023 May 12, 2023	BUY	$680.49 - $826.97 $6.59 Million - $8.01 Million	9,690 New	9,690 $7.96 Million
Q4 2020 Feb 16, 2021	SELL	$478.3 - $607.98 $6.79 Million - $8.63 Million	-14,200 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$544.75 - $658.21 $926,075 - $1.12 Million	1,700 Added 13.6%	14,200 $7.95 Million
Q2 2020 Aug 13, 2020	BUY	$493.32 - $643.92 $4.66 Million - $6.09 Million	9,453 Added 310.24%	12,500 $7.8 Million
Q1 2020 May 14, 2020	BUY	$336.18 - $494.43 $1.02 Million - $1.51 Million	3,047 New	3,047 $1.49 Million
Q3 2017 Nov 14, 2017	SELL	$431.38 - $504.0 $4.1 Million - $4.79 Million	-9,500 Closed	0 $0
Q2 2017 Aug 14, 2017	BUY	N/A	9,500	9,500 $4.67 Million

Others Institutions Holding REGN

# of Institutions

1,534

Shares Held

83.6M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $75.2B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Atika Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Atika Capital Management LLC with notifications on news.

Account

Atika Capital Management LLC Regeneron Pharmaceuticals, Inc. Transaction History